Susanna High

Susanna High

Chief Operating Officer at DYNE THERAPEUTICS, INC.

Net worth: 195 081 $ as of 29/04/2024

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Susanna G.
High
is currently the Chief Operating Officer at Dyne Therapeutics, Inc. She previously worked as the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019.
Prior to that, she was the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2015 to 2016.
From 2001 to 2007, she worked as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. Susanna's earliest job was as a Management Consultant at Accenture LLC from 1996 to 2001.
She received a graduate degree from the University of Bocconi and an MBA from MIT Sloan School of Management in 1996.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/05/2024 8,233 ( 0.01% ) 195 081 $ 29/04/2024

Susanna High active positions

CompaniesPositionStart
DYNE THERAPEUTICS, INC. Chief Operating Officer 30/06/2020
All active positions of Susanna High

Former positions of Susanna High

CompaniesPositionEnd
BLUEBIRD BIO, INC. Chief Operating Officer 03/01/2019
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 31/05/2008
Corporate Officer/Principal 31/12/2006
Corporate Officer/Principal 31/12/2000
See the detail of Susanna High's experience

Training of Susanna High

University of Bocconi Graduate Degree
MIT Sloan School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susanna High's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ALNYLAM PHARMACEUTICALS, INC.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

DYNE THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Commercial Services

See company connections